Psychedelics may catalyze rapid improvements in mental health, but they do so firmly rooted in what we already know about the efficacy of psychotherapy.
Alan K. Davis, PhD
Advertisement
Dr Davis is an associate professor and director of the Center for Psychedelic Drug Research and Education in the College of Social Work at the Ohio State University and an adjunct professor at Johns Hopkins.
Articles by Alan K. Davis, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Evidence-Based Psychotherapy and Psychopharmacology for Mood Disorders: A Conversation With Holly A. Swartz, MD
2
New Post-Hoc Analysis: Ingrezza 40 mg Leads to Clinically Meaningful Improvements in Tardive Dyskinesia Symptoms
3
Can the Initial Antipsychotic Influence Years of Weight Gain?
4
Loneliness, Meet Solitude
5
